
Cracking the Code: Understanding Congenital Hydrocephalus Through Genetic Testing
Explore how genetic testing enhances understanding, diagnosis, and personalized treatment of congenital hydrocephalus, improving outcomes and guiding family planning.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing enhances understanding, diagnosis, and personalized treatment of congenital hydrocephalus, improving outcomes and guiding family planning.

Explore how genetic testing uncovers mutations in the NEB gene, aiding diagnosis and management of congenital myopathy with cores, a rare muscle disorder.

Explore how genetic testing detects PTEN mutations, guides cancer screening, supports family planning, and offers hope for managing Cowden Syndrome effectively.

Unlock insights into craniofacial microsomia with genetic testing. Learn about SF3B2's role, early diagnosis benefits, personalized treatments, and family planning.

Unlock precise diagnosis and treatment for Cranioosteoarthropathy with genetic testing. Identify mutations, tailor treatments, and enable early interventions.

Explore how genetic testing enhances craniosynostosis syndrome diagnosis, enables personalized treatment, and supports family planning for better patient outcomes.

Explore the role of genetic testing in diagnosing Cryopyrin Associated Periodic Syndrome (CAPS) and Muckle-Wells syndrome for accurate diagnosis and personalized treatment.

Explore cutis laxa, a rare connective tissue disorder. Genetic testing aids diagnosis, informs treatment, and guides research for better patient outcomes.